GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $47,969,000 | -7.8% | 1,501,382 | 0.0% | 2.74% | +15.5% |
| Q1 2022 | $52,008,000 | +39.3% | 1,501,382 | +17.7% | 2.37% | +24.6% |
| Q4 2021 | $37,343,000 | +14.9% | 1,275,800 | 0.0% | 1.90% | +19.1% |
| Q3 2021 | $32,507,000 | -27.2% | 1,275,800 | 0.0% | 1.60% | -11.0% |
| Q2 2021 | $44,679,000 | +27.1% | 1,275,800 | +34.4% | 1.80% | +12.7% |
| Q1 2021 | $35,161,000 | +450.8% | 948,968 | +543.8% | 1.60% | +442.5% |
| Q4 2020 | $6,384,000 | – | 147,400 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |